We are committed to keeping our clients informed on the latest clinical trends affecting your plan, clients and members. That’s why we have partnered with subject matter experts inside of Express Scripts to bring you exclusive thought leadership on industry trends and how we can partner with you to tackle these challenges. Below you will find a variety of information about the latest clinical trends we are facing. As new content is available, you will be notified to check back! If you have any questions or want to continue the conversation on any of the topics below, please reach out to your Clinical Account Executive (CAE).
Clinical Insights Forum
Emerging Therapeutics Update
COVID-19 Update- 0:50- Chris Peterson
Biosimilar Update- 8:52- Chris Peterson
Patent Expirations- 12:10- Chris Peterson
Traditional Pipeline- 15:10- AJ Steil
Specialty Pipeline- 29:03 - Aimee Tharaldson
Biosimilar Update- 8:52- Chris Peterson
Patent Expirations- 12:10- Chris Peterson
Traditional Pipeline- 15:10- AJ Steil
Specialty Pipeline- 29:03 - Aimee Tharaldson
Harold Carter on Biosimilars
Listen to Harold Carter, Chief Pharma Trade Relations Officer, discuss Biosimilars at Outcomes+ 2022
Subject Matter Clinical Insights
Emerging Therapeutics
Solutioning Together
Read more about Evernorth and Express Scripts solutions below:
Evernorth Insights
Read the latest insights from Evernorth.
